VACC to seek probe into alleged anomalous purchase of dengue vaccines

admin   •   December 4, 2017   •   4782

Anti-dengue vaccine: Dengvaxia

MANILA, Philippines — The group of Volunteers against Crime and Corruption (VACC) is expected to file a formal request at the Department of Justice (DOJ) and National Bureau of Investigation (NBI) to conduct an investigation regarding the anomalous purchase of 3.5 billion- peso anti-dengue vaccine.

The dengue immunization program of the DOH is seen as a serious case because of the possible health risks to children particularly those who have not yet been infected with dengue.

VACC founding chairman, Dante Jimenez said, whoever was behind this should be held accountable.

“We will file a letter first in DOJ and NBI requesting for an investigation on this scam,” he said.

The VACC has talked to an alleged witness who has knowledge of the whole purchasing process of the controversial vaccine.

He also suggested the placement of DOH complaint desks at different schools, where parents can address their concerns about their children who received the vaccination.

 “We will urge also the government to pay you [parents] damages. Kaya dapat DOH magset-up kayo ng centers nationwide (That is why DOH must set up centers nationwide). Lagay kayo ng mga complaints sinu-sino yung mga nagpa-vaccine diyan (set up complaint desks to track who received the vaccines),” said Jimenez.

Data from the Department of Health (DOH) shows that more than 700,000 students have been vaccinated by the anti-dengue vaccine.

Last Friday, the DOH already ordered to temporarily suspend the dengue immunization program, while waiting for the recommendation from experts in the World Health Organization (WHO). — UNTV News & Rescue

 

Gordon files bill to expand country’s pool of vaccinators

Aileen Cerrudo   •   January 21, 2021

Manila, Philippines — Senator Richard Gordon has filed a bill seeking to expand the country’s pool of vaccinators for the immunization program of the government.

Gordon, in a statement, said Senate Bill No. 1987 will allow training for other members in the medical field, as well as, non-medical practitioners.

“Since we have a limited number of doctors, nurses, and midwives that will aid in the COVID-19 vaccination program, we filed a bill that expands the pool of vaccinators of the DOH by training other professionals such as dentists, veterinarians, medical technologists, and even those without a medical background to be vaccinators,” he said.

Section 1 of Senate Bill No. 1987 states that non-medical practitioners that will be part of the training will be allowed provided that they will be given the appropriate training, certification and authority by the Department of Health (DOH), and that they will perform their duties under the supervision of a duly registered physician and for a limited period only contingent upon the existence of the national health emergency for which it is called.

Non-medical practitioners will be given appropriate training, certification, and authority by the Department of Health (DOH).

The filed bill also states that the trained individuals will perform their duties under the supervision of a duly registered physician and for a limited period only, subject to the existence of a national health emergency.

“If we expand the manpower for the vaccination program, the government’s target of inoculating 50 to 70 million Filipinos to be able to achieve herd immunity or population immunity can be attained,” Gordon added.

According to the DOH, only 617,239 health care workers from both public and private health institutions will be able to help in administering the COVID-19 vaccines. -AAC

PH to get COVID-19 vaccines from COVAX in Q1 2021 – DOH

Robie de Guzman   •   January 21, 2021

MANILA, Philippines – The Department of Health (DOH) announced that the Philippines has received confirmation of its participation in the COVID-19 vaccine financing instrument – COVAX facility – Advance Market Commitment.

The COVAX Facility, an initiative of the World Health Organization (WHO), is a global procurement mechanism which invests in a broad portfolio of promising vaccine candidates to support their research, development, and manufacturing.

This facility was setup to ensure fair and equitable access to COVID-19 vaccines.

“With the country’s participation in the COVAX Facility, the country is set to receive vaccines in the first quarter of this year,” the DOH said in a statement on Wednesday.

As part of the preparations for the COVID-19 vaccine deployment, Health Secretary Francisco Duque III and Vaccine Czar Secretary Carlito Galvez, Jr. on Wednesday visited three cold storage facilities that can potentially be used in the first wave of COVID-19 vaccine roll-out.

The cold chain facilities visited were the First Pioneer Distribution Center of UNILAB located in Biñan City, Laguna, the Research Institute of Tropical Medicine (RITM) in Muntinlupa City, and the Zuellig Pharma Corporation in Parañaque City.

“The inspection was carried out to ensure that the cold chain facilities will meet the storage requirement of vaccines prior to its distribution to identified vaccination sites,” the DOH said.

UNILAB’s cold storage facility has a temperature range of +2 to +8 °C and can store a maximum of five million doses of vaccines.

Meanwhile, Zuellig Pharma reported that its facilities can accommodate pharmaceutical products with temperature requirements ranging between -80°C to +25 °C. Its cold rooms with temperature ranging from +2 to +8 °C can store up to 629 million doses in various warehouses, its -15 to -25 °C walk-in freezers can hold up to 40 million doses, and its 14 ultra-cold freezers with -80 to -70 °C temperature range has the capacity to store up to 6.5 million doses.

“The vaccine cluster, on behalf of the government, is grateful to UNILAB and Zuellig Pharma for partnering with the government in further strengthening the country’s capacity to curb the pandemic. We also express our commitment to ensure continued support for RITM in its preparations to receive vaccines,” Galvez said.

RITM Director Dr. Celia Carlos said that RITM currently has four cold rooms with a +2 to +8 °C temperature range, one -20 °C walk-in freezer, and two borrowed ultra-low temperature freezers with a -70 to -80 °C temperature range. Presently, RITM commits its ultra-low temperature storage facility.

With this, the DOH said that Galvez has recommended the constitution of another team at the RITM exclusively handling the COVID-19 vaccine deployment, adding that a separate team for EPI (Expanded Program of Immunization) vaccines is ideal for an uninterrupted focus and roll-out of both immunization programs.

Duque, on the other hand, noted that aside from cold chain facilities, the vaccine cluster is also in talks with third-party logistics providers to ensure efficiency of the entire supply chain management of COVID-19 vaccines, from the receipt of vaccines from the COVAX Facility to its deployment.

“All of these preparations that we are undertaking are aimed at ensuring that the country is ready to receive, store, and mobilize the COVID-19 vaccines that will come from the COVAX Facility,” Duque said.

EUA on Pfizer vaccine won’t be revoked yet despite Norway deaths, DOH says

Robie de Guzman   •   January 18, 2021

MANILA, Philippines — The emergency use authorization (EUA) issued last week by the Food and Drug Administration (FDA) to drug-maker Pfizer-BioNTech for its COVID-19 vaccine will not be revoked yet pending an investigation into claims that it caused the death of some elderly people in Norway, the Department of Health (DOH) said Monday.

Health Undersecretary Maria Rosario Vergeire said Norwegian authorities are still looking into reports that 23 individuals aged 75 to 80 with underlying health conditions died after getting inoculated with COVID-19 vaccine developed by Pfizer-BioNTech.

Vergeire also said that studies need to be done on the matter.

“Pfizer has to submit a report to the Philippine Food And Drug Administration regarding this matter. Once we evaluate the report, base sa kanilang conclusion, that’s the time FDA can decide on the EUA of Pfizer. For now,” Vergeire said.

“Hanggang wala pang sufficient evidence that it was caused by vaccines, status quo tayo on this EUA given to Pfizer,” she added.

The FDA granted EUA to Pfizer last January 14, the first out of four applications it received so far. Other applications are AstraZeneca, China’s Sinovac, and Russia’s Gamaleya Institute.

FDA Director-General Eric Domingo said they are still awaiting a report from Norwegian authorities and that they will “revise the conditions of the EUA as needed,” before starting vaccinations as part of the agency’s protocols on the use of vaccines.

Health authorities also reiterated that COVID-19 vaccines will go through stringent evaluation before it can be approved for use in the country.

“Aside from the safety, and the efficacy na meron ang mga bakuna na papasok, titingnan din nila iyon pong social impact nito, titingnan nila ang affordability and titingnan nila sa response ng equity,” Vergeire said.

“They will be evaluating and then they give their recommendation to the Secretary. Kapag positive ang recommendation, we can procure the specific vaccine,” she added. – RRD (with details from Correspondent Aiko Miguel)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.